Dermatology And Therapy

Dermatology And Therapy

皮肤科和治疗

  • 2区 中科院分区
  • Q1 JCR分区

期刊简介

《Dermatology And Therapy》是由Springer Healthcare出版社于2011年创办的英文国际期刊(ISSN: 2193-8210,E-ISSN: 2190-9172),该期刊长期致力于皮肤病学领域的创新研究,主要研究方向为Medicine-Dermatology。作为SCI、SCIE收录期刊(JCR分区 Q1,中科院 2区),本刊采用OA开放获取模式(OA占比1%),以发表皮肤病学领域等方向的原创性研究为核心(研究类文章占比80.07%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在276篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Dermatology And Therapy审稿周期约为6 Weeks。该刊近年未被列入国际预警名单,年发文量约276篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 276 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
2区
DERMATOLOGY 皮肤病学
2区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
DERMATOLOGY 皮肤病学
2区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
DERMATOLOGY 皮肤病学
3区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
DERMATOLOGY 皮肤病学
2区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
DERMATOLOGY 皮肤病学
3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:DERMATOLOGY SCIE Q1 11 / 99

89.4

学科:DERMATOLOGY SCIE Q1 16 / 99

84.34

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:DERMATOLOGY SCIE Q1 20 / 94

79.3

学科:DERMATOLOGY SCIE Q1 19 / 94

80.32

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:7.3 SJR:1.595 SNIP:1.589
学科类别 分区 排名 百分位
大类:Medicine 小类:Dermatology Q1 9 / 152

94%

期刊发文

  • Pathological Insights into the Limitations of Clinical and Dermoscopic Evaluations in Monitoring Sonidegib Treatment Response for Locally Advanced Basal Cell Carcinoma: A Real-World Stud

    Author: Liu, Xurong; Zhan, Jipang; Zou, Jingwen; Chen, Rongyi; Zhong, Jing; He, Renliang

    Journal: DERMATOLOGY AND THERAPY. 2026; Vol. 16, Issue 3, pp. 1779-1794. DOI: 10.1007/s13555-026-01675-4

  • HS-20137 for Chinese Moderate-to-Severe Psoriasis: A Randomized, Double-Blinded, Phase 2 Stud

    Author: Cai, Lin; Wang, Xiaohua; Zhang, Litao; Zhang, Guoqiang; Wu, Liming; Yang, Baoqi; Meng, Zudong; Shi, Jihai; Han, Guangming; Wei, Aihua; Li, Shanshan; Zhao, Yi; Su, Juan; Wei, Nianjin; Liu, Siying; Liu, Ran; Liu, Wei; Fang, Min; Zhang, Xiaoqing; Zhang, Jianzhong

    Journal: DERMATOLOGY AND THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s13555-026-01694-1

  • Real-World Characteristics, Treatment Patterns, and Outcomes in Adult Patients Receiving Abrocitinib for Atopic Dermatitis in China: Interim Analysis from the AHEAD Registr

    Author: Zhang, Li; Zhou, Naihui; Wu, Zhouwei; Chen, Xuejun; Zhu, Huilan; Li, Shanshan; Han, Jianwen; Miao, Guoying; Wu, Liming; Zhu, Rongfei; Lu, Jianyun; Zheng, Yue; Jiang, Xian; Cao, Xianwei; Yu, Dehou; Zhang, Siping; Ding, Yangfeng; Man, Xiaoyong; Cui, Yong; Li, Ying; Dou, Xia; Gao, Xinghua

    Journal: DERMATOLOGY AND THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s13555-026-01655-8

  • The Diagnosis and Treatment Technology of Port-Wine Stain, and the Prospect of Future Treatmen

    Author: Li, Minghui; Song, Yang; Zhou, Junfeng

    Journal: DERMATOLOGY AND THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s13555-026-01651-y

  • Impacts of Topical Treatments and Phototherapy on Stratum Corneum Hydration, Sebum and Elasticity in Vitiligo Ski

    Author: Wen, Yaqing; Issa, Issa Ali; Lei, Li; Fu, Chuhan; Zhou, Shu; Zhang, Keyi; Huang, Jiangfeng; Chen, Jing; Zeng, Qinghai; Jiang, Ling

    Journal: DERMATOLOGY AND THERAPY. 2025; Vol. 15, Issue 5, pp. 1163-1171. DOI: 10.1007/s13555-025-01398-y

  • Integrative Proteomics and Genomics Identify Novel Biomarkers and Therapeutic Targets in Vitiligo via Mendelian Randomizatio

    Author: Yan, Chenjue; Jiang, Ling; Hu, Yibo; You, Ting; Chen, Jing; Wu, Songjiang

    Journal: DERMATOLOGY AND THERAPY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s13555-025-01448-5

  • Transforming Aesthetic Dermatology: The Role of Artificial Intelligence in Skin Healt

    Author: Chen, Xiang; Zhou, Zhaokang; Ding, Hui; Zheng, Huiying; Ge, Yiping

    Journal: DERMATOLOGY AND THERAPY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s13555-025-01459-2

  • Investigation of the Efficacy and Safety of Xeligekimab (GR1501) in Patients with Moderate-to-Severe Plaque Psoriasis: A Multicenter, Randomized, Double-Blind Phase II Clinica

    Author: Cai, Lin; Li, Chengxin; Li, Shanshan; Zhang, Xiaodong; Wang, Gang; Yu, Jianbin; Huang, Kun; Fang, Hong; Ding, Yangfeng; Wang, Jinyan; Jiang, Congjun; Lu, Qianjin; Tao, Juan; Zhang, Jianzhong

    Journal: DERMATOLOGY AND THERAPY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s13555-025-01450-x